欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/0013/001
药品名称Humatrope 1.33 mg
活性成分
    • somatropin 5.33 mg
剂型Powder and solvent for solution for injection
上市许可持有人Eli Lilly and Company Eli Lilly European regulatory team Lilly research centre Erlwood Manor Windlesham Surry GU20 6PH United Kingdom e-mailaddress: houdali_Basel@Lilly.com
参考成员国 - 产品名称Netherlands (NL)
互认成员国 - 产品名称
    • Denmark (DK)
      Humatrope 4 IE (1,33 mg)
    • Belgium (BE)
      Humatrope 4 IE (1,33 mg)
    • Luxembourg (LU)
      Humatrope
    • United Kingdom (Northern Ireland) (XI)
      Humatrope 4 IE (1,33 mg)
    • Ireland (IE)
      Humatrope 4 IE (1,33 mg)
    • France (FR)
      Humatrope 4 IE (1,33 mg)
    • Spain (ES)
      Humatrope 4 IE (1,33 mg)
    • Portugal (PT)
      Humatrope 4 IE (1,33 mg)
    • Italy (IT)
      Humatrope 4 IE (1,33 mg)
    • Greece (GR)
      Humatrope 4 IE (1,33 mg)
    • Sweden (SE)
      Humatrope 4 IE (1,33 mg)
    • Finland (FI)
      Humatrope 4 IE (1,33 mg)
许可日期1990/12/12
最近更新日期2024/08/19
药物ATC编码
    • H01AC01 somatropin
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：[not specified]
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase